Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure

Expert Review of Anticancer Therapy
Concetta Elisa OnestiPaolo Marchetti

Abstract

Here, we evaluate clinical trials on chemotherapy for patients with pancreatic or biliary tract cancer after first-line treatment failure. Clinical trials on conventional and innovative medical treatments for progressive pancreatic and biliary cancer were analyzed. Metronomic chemotherapy, which consists of the administration of continuative low-dose of anticancer drugs, was also considered. A significant extension of overall survival was achieved with second-line, regimens in patients with gemcitabine-refractory pancreatic cancer. Moreover, many Phase II studies, including chemotherapy and target molecules and immunotherapy, have reported promising results, in both pancreatic and biliary cancer. However, data in these patients' setting are very heterogeneous, and only few randomized studies are available.

References

Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Mar 19, 2004·The New England Journal of Medicine·John P NeoptolemosUNKNOWN European Study Group for Pancreatic Cancer
Mar 29, 2005·The Oncologist·Howard A BurrisArthur Staddon
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Scott D YoungColin J Germond
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip A PhilipCharles Erlichman
Jan 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BoeckV Heinemann
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeCharles S Fuchs
Apr 10, 2008·Cancer Chemotherapy and Pharmacology·Chigusa MorizaneEiichiro Suzuki
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Douglas B EvansRobert A Wolff
Sep 4, 2008·Cancer Chemotherapy and Pharmacology·Yoon Jae KimSi Young Song
Oct 8, 2008·Cancer Chemotherapy and Pharmacology·Seong Yoon YiWon Ki Kang
Nov 5, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Avo ArtinyanJoseph Kim
Dec 3, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian M WolpinCharles S Fuchs
Jan 27, 2009·Cancer Chemotherapy and Pharmacology·Ramesh K RamanathanDavid R Gandara
Feb 4, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Tudor E CiuleanuGeorge T Tidmarsh
Feb 6, 2009·American Journal of Clinical Oncology·Anna NovarinoLibero Ciuffreda
May 20, 2009·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Richard D CarvajalEileen M O'Reilly
Nov 26, 2009·British Journal of Cancer·C BengalaP Conte
Feb 5, 2010·Cancer Chemotherapy and Pharmacology·Andrew H KoMargaret A Tempero
Mar 2, 2010·Japanese Journal of Clinical Oncology·Akiko TodakaHideharu Tomita
Mar 31, 2010·Cancer Chemotherapy and Pharmacology·Kentaro SudoOsamu Yokosuka
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
Sep 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Atul SharmaSurendra Pal Chaudhary

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
John BridgewaterJuan Valle
© 2021 Meta ULC. All rights reserved